Bristol Myers Squibb offers 15-20% upside despite patent cliff fears, backed by strong pipeline and CAR-T innovations.

Bristol Myers Squibb's 4.39% dividend yield remains safe despite slower growth and elevated debt.

Bristol Myers Squibb offers a 4.39% dividend yield backed by 94 years of payments, with a payout ratio near 41% and strong cash flow coverage. Despite elevated net debt of $33.6 billion, manageable leverage and a dovish Fed reduce refinancing risks. ...